Clinical characteristics and etiology-specific outcome in pediatric hypertrophic cardiomyopathy [0.03%]
儿童肥厚型心肌病的临床特征和病因特异性预后
Felix Minette,Maximilian Klass,Nikita Meyer et al.
Felix Minette et al.
Introduction: Childhood-onset cardiomyopathies are rare disease (incidence 1/100,000) presenting with diverse, potentially severe phenotypes. The etiologies range from idiopathic/sarcomeric forms to syndromic diseases, ne...
Letter to the Editor: 250th cardiac arrest center certification in Germany [0.03%]
论点信：德国第250个心脏骤停中心认证
N Rott,H J Busch,N Frey et al.
N Rott et al.
Prognostic value of SYNTAX score, intravascular ultrasound and near-infrared spectroscopy in coronary disease: 12-year follow-up of ATHEROREMO [0.03%]
SYNTAX评分、血管内超声和近红外光谱成像对冠状动脉疾病的预后价值：ATHEROREMO研究12年随访结果
Victor G Meuleman,Alexander Vanmaele,Jose M Da Veiga Fernandes de Mira et al.
Victor G Meuleman et al.
Background and aims: This study aims to investigate the very long-term predictive value of the SYNTAX score and plaque characteristics derived by intravascular ultrasound (IVUS) as well as near-infrared spectroscopy (NIRS...
Sex-specific influence of Lipoprotein(a) levels on coronary plaque characteristics: - The COPRODUCTION Registry [0.03%]
脂蛋白(a)水平对冠状动脉斑块特征性别差异的影响:COPRODUCTION注册研究
Philipp Breitbart,Christoph Liebetrau,Dimitri Grün et al.
Philipp Breitbart et al.
Background: Elevated Lipoprotein(a) Lp(a) levels are associated with coronary atherosclerosis as detected by cardiac computed tomography angiography (CCTA). However, quantitative data including coronary plaque volumes and...
Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy [0.03%]
梗阻性肥厚型心肌病经冠状动脉消蚀隔膜成形术和外科手术治疗的长期趋势、患者特征及医院量outcome分析
Peter Moritz Becher,Fabian J Brunner,Jessica Weimann et al.
Peter Moritz Becher et al.
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary cardiac disease associated with poor prognosis. Data on septal reduction therapy (SRT), including transcoronary ablation of septal hypertrophy (TA...
Association of apolipoprotein B, excess apolipoprotein B and apoB/apoA1 ratio with 20-year atherosclerotic cardiovascular disease risk: the ATTICA study (2002-2022) [0.03%]
载脂蛋白B、多余载脂蛋白B和apoB/apoA1比值与20年动脉粥样硬化性心血管疾病风险关系：ATTICA研究(2002-2022)
Sofia-Panagiota Giannakopoulou,Christina Chrysohoou,Smaragdi Antonopoulou et al.
Sofia-Panagiota Giannakopoulou et al.
Background: This study investigated the relationship between apolipoprotein B (apoB), "excess apoB" (apoB beyond low-density lipoprotein cholesterol (LDL-C)), and apoB/apolipoprotein A1 (apoA1) ratio with 20-year atherosc...
Sex differences in the initiation of antithrombotic therapy in patients with atrial fibrillation in Germany [0.03%]
德国心房颤动患者抗凝治疗的性别差异
Jamschid Sedighi,Mark Luedde,Boris Dinov et al.
Jamschid Sedighi et al.
Background and aims: Despite guidelines recommending antithrombotic therapy for atrial fibrillation (AF) patients, differences in treatment initiation between sex remain an area of ongoing research. This study assesses th...
Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022-2024) [0.03%]
德国低剂量抗血栓和抗炎疗法处方的 temporal趋势（2022-2024）
Michael Kunz,Andrea Espinosa Daudí,Marita Kieble et al.
Michael Kunz et al.
Aims: This study aimed to investigate the prescription rates of low-dose antithrombotic and anti-inflammatory therapies in Germany from 2022 to 2024. Meth...
Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR [0.03%]
纤维蛋白血凝块强度与TAVR术后主要不良心血管事件风险增加有关
David Hesselbarth,Michelle D&#x;Orazio,Giovanni Ciccarone et al.
David Hesselbarth et al.
Background: Patients after transcatheter aortic valve replacement (TAVR) are at increased risk of both major adverse cardiac events (MACE), including ischemic and thrombotic complications, as well as significant bleeding....
Response to the Letter: "C-reactive protein-to-albumin ratio in transcatheter tricuspid valve repair: methodological concerns and inconsistencies" [0.03%]
针对信函的回复："经导管三尖瓣修复术中C反应蛋白-白蛋白比率：方法学问题与不一致之处"
Karl Finke,Laura Marx,Jan Althoff et al.
Karl Finke et al.